thyroxine has been researched along with Diabetic Angiopathies in 5 studies
Thyroxine: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
thyroxine : An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.
Diabetic Angiopathies: VASCULAR DISEASES that are associated with DIABETES MELLITUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "CV = cardiovascular DMN = diabetic nephropathy eGFR = estimated glomerular filtration rate fT4 = free thyroxine HbA1c = glycosylated hemoglobin HR = hazard ratio hs-CRP = high-sensitivity C-reactive protein LDL-C = low-density lipoprotein cholesterol SCH = subclinical hypothyroidism T2DM = type 2 diabetes THRT = thyroid hormone replacement therapy TSH = thyroid-stimulating hormone." | 3.88 | THYROID HORMONE REPLACEMENT REDUCES THE RISK OF CARDIOVASCULAR DISEASES IN DIABETIC NEPHROPATHY PATIENTS WITH SUBCLINICAL HYPOTHYROIDISM. ( Cha, MU; Han, SH; Jhee, JH; Kang, SW; Kee, YK; Kim, H; Kim, S; Lee, M; Park, JT; Park, S; Seo, C; Yoo, TH; Yun, HR, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Seo, C | 1 |
| Kim, S | 1 |
| Lee, M | 1 |
| Cha, MU | 1 |
| Kim, H | 1 |
| Park, S | 1 |
| Yun, HR | 1 |
| Jhee, JH | 1 |
| Kee, YK | 1 |
| Han, SH | 1 |
| Yoo, TH | 1 |
| Kang, SW | 1 |
| Park, JT | 1 |
| TEUSCHER, A | 1 |
| Jung, CH | 1 |
| Rhee, EJ | 1 |
| Shin, HS | 1 |
| Jo, SK | 1 |
| Won, JC | 1 |
| Park, CY | 1 |
| Kim, BJ | 1 |
| Sung, KC | 1 |
| Kim, BS | 1 |
| Lee, WY | 1 |
| Oh, KW | 1 |
| Kang, JH | 1 |
| Park, SW | 1 |
| Lee, MH | 1 |
| Kim, SW | 1 |
| Waber, S | 1 |
| Meister, V | 1 |
| Rossi, GL | 1 |
| Mordasini, RC | 1 |
| Riesen, WF | 1 |
| Albrink, MJ | 1 |
1 review available for thyroxine and Diabetic Angiopathies
| Article | Year |
|---|---|
Dietary and drug treatment of hyperlipidemia in diabetes.
Topics: Arteriosclerosis; Blood Protein Disorders; Body Weight; Cholestyramine Resin; Clofibrate; Diabetes M | 1974 |
4 other studies available for thyroxine and Diabetic Angiopathies
| Article | Year |
|---|---|
THYROID HORMONE REPLACEMENT REDUCES THE RISK OF CARDIOVASCULAR DISEASES IN DIABETIC NEPHROPATHY PATIENTS WITH SUBCLINICAL HYPOTHYROIDISM.
Topics: Aged; Asymptomatic Diseases; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathi | 2018 |
[HYPOPHYSECTOMY FOR SEVERE DIABETES].
Topics: Adolescent; Cortisone; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic | 1963 |
Higher serum free thyroxine levels are associated with coronary artery disease.
Topics: Aged; Coronary Angiography; Coronary Disease; Diabetes Mellitus; Diabetic Angiopathies; Female; Huma | 2008 |
Studies on retinal microangiopathy and coronary macroangiopathy in rats with streptozotocin-induced diabetes.
Topics: Animals; Basement Membrane; Coronary Disease; Diabetes Mellitus, Experimental; Diabetic Angiopathies | 1981 |